Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

539
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
539
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

1.1K
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
1.1K
Pulmonary Function Tests01:25

Pulmonary Function Tests

718
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
718
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

COPD maintenance trials use heterogeneous outcomes and measurement instruments: a systematic literature review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

COPD Trial Evidence Comes From a Narrow Slice of the World: A Population Representativeness Analysis.

Chest·2026
Same author

ERS Congress 2025: highlights from the Airway Diseases Assembly.

ERJ open research·2026
Same author

Find your career: the ERS "My Career Path" series.

Breathe (Sheffield, England)·2026
Same author

Blood eosinophil count as a biomarker for therapy guidance in COPD and asthma exacerbations.

Breathe (Sheffield, England)·2026
Same author

Energy and Protein Intake in Mild-Moderate COPD Patients.

Lung·2026

相关实验视频

Updated: Jan 10, 2026

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K

在COPD中皮细胞因子的重复性

Alex Mulvanny1, Augusta Beech1,2, Jian Li2

  • 1Bioanalytical Department, Medicines Evaluation Unit, Manchester, UK.

International journal of chronic obstructive pulmonary disease
|November 27, 2025
PubMed
概括

在COPD患者的唾液生物标志物测量显示,在六个月内具有很高的重复性. 唾液中的这些可重现的炎症特征与中性恋和细菌殖民等临床因素有关.

科学领域:

  • 肺部医学 肺部医学
  • 生物标志物发现发现
  • 慢性阻塞性肺病 (COPD) 是一种慢性阻塞性肺病.

背景情况:

  • 唾液生物标志物测量对于评估COPD患者的呼吸道炎症至关重要.
  • 之前经过验证的Luminex试验量化了COPD唾液上浮体中的15种分析物,揭示了与中性恋,细菌殖民和吸烟有关的概况.

研究的目的:

  • 评估COPD患者在六个月内脏生物标志物测量的可重复性.
  • 为了确定液炎症标志物和六个月的临床特征之间的相关性.

主要方法:

  • 在6个月后,对48名COPD患者进行了重复的唾液超分析.
  • 多重免疫试验量化了唾液样本中的15种分析物质.
  • 使用统计分析,包括类内相关系数 (ICC),来评估可重复性和相关性.

主要成果:

  • 大多数唾液分析物在基线和六个月 (ICC) 之间表现出良好的至出色的重复性.
  • 特定的细胞因子 (IL-1β,IL-2,IL-8,IL-17A,G-CSF,MIP-1α,MIP-1β,TNF-α) 与六个月后的唾液中性细胞百分比相关.
  • 在患有*Haemophilus influenzae*定居的患者和前吸烟者COPD患者中观察到某些细胞因子的水平升高.
关键词:
生物标志物生物标志物这是一种炎症炎症炎症炎症.卢米内克斯 (Luminex) 公司呼吸道 呼吸道 呼吸道验证验证的时间

更多相关视频

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

5.8K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

677

相关实验视频

Last Updated: Jan 10, 2026

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K
Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

5.8K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

677

结论:

  • 唾液生物标志物的多重免疫试验显示,慢性慢性病患者随着时间的推移具有很高的可重复性.
  • 唾液中的可复制炎症特征与COPD的关键临床特征有关,包括中性恋,细菌殖民和吸烟状态.